Clinical observations show that vitamin D administered at high doses helps to overcome these side effects, especially in postmenopausal women with breast cancer who are treated with aromatase inhibitors and usually have vitamin D deficiency [5,6,7,8,9]. The gene discussed is CYP19A1; the disease is breast carcinoma.